Transplants and Risk Adapted Maintenance in Myeloma Treatment

56:00
 
Share
 

Manage episode 224472296 series 1143960
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.
The treatment paradigm for myeloma patients has changed in the last decade with important advancements such as proteasome inhibitors, IMiDS, antibodies and risk-adapted maintenance. How a patient responds to therapy can be used to determine how long the maintenance or follow-up therapy should be. This is called risk-adapted therapy and personalizes myeloma care. The myeloma panel is talking to Dr. Sagar Lonial of Winship Cancer Institute of Emory University, to learn how he uses genetic and disease risk factors to personalize maintenance strategies after stem cell transplants for his patients with multiple myeloma. RSVP here!

159 episodes available. A new episode about every 20 days averaging 61 mins duration .